RNA
gard-337

Part:BBa_K3714000

Designed by: Yuxin Lu   Group: iGEM21_SJTU-BioX-Shanghai   (2021-08-30)
Revision as of 01:29, 22 October 2021 by Grus (Talk | contribs)


Gardiquimod biosensor 337

The template of a new self-cleaving aptazyme[1], which keeps itself intact with gardiquimod present, and catalyzes the self-cleavage reaction in the absence of gardiquimod. This part could be used as a switch for gene expression controlled by gardiquimod. The feature "Aptazyme" is necessary, and two A-rich oligonucleotides are added at both terminal to avoid unwanted secondary structure.

Usage and Biology

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

This aptazyme was found in a random oligonucleotide library designed based on ribozyme sTRSV. The two loops of native sTRSV were replaced by two random sequences, which might form an aptamer domain, affecting the activity of ribozyme. We intended to use this aptazyme to validate our design of an colloidal gold based detection platform. So we tested its activity in advance(Fig.1).

K3714000.png
Figure.1 | Verification of biosensor gard-337. An in vitro transcription system was employed to test if this biosensor can response gardiquimod signal. The product was run on a denatured PAGE.

Reference
[1] Townshend, B., Xiang, J. S., Manzanarez, G., Hayden, E. J. & Smolke, C. D. A multiplexed, automated evolution pipeline enables scalable discovery and characterization of biosensors. Nature Communications 12, 1437, doi:10.1038/s41467-021-21716-0 (2021).

[edit]
Categories
//rna/aptazyme
Parameters
efficiency10 μM gardiquimod inhibits 94.4% cleavage[1]